Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Liver > DLV8013a
  • Cores:
    80
    CASES:
    40
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    10
    Tissue Array Type:
    FFPE
    Species:
    Human
DLV8013a
$225.00
Add To Collect

Description: Hepatocellular carcinoma with normal tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing DLV8013

Details: Hepatocellular carcinoma with normal tissue microarray, containing 20 cases of hepatocellular carcinoma, 10 cirrhosis and 10 adjacent normal liver tissue, duplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Cirrhosis(*)
  • NAT(*)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IVA)
  • _ma
TISSUE ARRAYS
DLV8013a
1
2
3
4
5
6
7
8
9
10
A
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
B
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
C
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
D
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
E
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
F
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
G
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
H
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
_ma
DLV8013a
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 63 M Liver Hepatocellular carcinoma 1 T3N0M0 IIIA Malignant *
A2
2 63 M Liver Hepatocellular carcinoma 1 T3N0M0 IIIA Malignant *
A3
3 65 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant *
A4
4 65 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant *
A5
5 62 F Liver Hepatocellular carcinoma (sparse) 1--2 T3N0M0 IIIA Malignant *
A6
6 62 F Liver Hepatocellular carcinoma 1--2 T3N0M0 IIIA Malignant *
A7
7 58 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 7*7*6
A8
8 58 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 7*7*6
A9
9 72 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5.5*5.0*3.5
A10
10 72 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5.5*5.0*3.5
B1
11 57 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 6.5*5.0*3.5
B2
12 57 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 6.5*5.0*3.5
B3
13 48 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant *
B4
14 48 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant *
B5
15 40 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant *
B6
16 40 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant *
B7
17 60 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant *
B8
18 60 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant *
B9
19 51 F Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant *
B10
20 51 F Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant *
C1
21 47 M Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant 2
C2
22 47 M Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant 2
C3
23 60 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 8.0*7*5
C4
24 60 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 8.0*7*5
C5
25 27 M Liver Hepatocellular carcinoma 3 T3N1M0 IVA Malignant 11*11
C6
26 27 M Liver Hepatocellular carcinoma 3 T3N1M0 IVA Malignant 11*11
C7
27 52 F Liver Hepatocellular carcinoma with necrosis 3 T2N0M0 II Malignant 6.0*4.5*4.5
C8
28 52 F Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant 6.0*4.5*4.5
C9
29 45 M Liver Hepatocellular carcinoma with necrosis and degeneration 3 T2N0M0 II Malignant *
C10
30 45 M Liver Hepatocellular carcinoma with degeneration 3 T2N0M0 II Malignant *
D1
31 51 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 14*8*4.5
D2
32 51 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 14*8*4.5
D3
33 66 M Liver Hepatocellular carcinoma 3 T2N1M0 IVA Malignant 5
D4
34 66 M Liver Hepatocellular carcinoma 3 T2N1M0 IVA Malignant 5
D5
35 77 F Liver Hepatocellular carcinoma with necrosis 3 T3N0M0 IIIA Malignant 7
D6
36 77 F Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 7
D7
37 51 M Liver Hepatocellular carcinoma (sparse) 3 T3aN1M0 IVA Malignant 6
D8
38 51 M Liver Hepatocellular carcinoma 3 T3aN1M0 IVA Malignant 6
D9
39 69 M Liver Hepatocellular carcinoma with necrosis 3 T3N1M0 IVA Malignant 7
D10
40 69 M Liver Hepatocellular carcinoma with necrosis 3 T3N1M0 IVA Malignant 7
E1
41 34 M Liver Cirrhosis * * * Cirrhosis *
E2
42 34 M Liver Cirrhosis * * * Cirrhosis *
E3
43 62 M Liver Cirrhosis * * * Cirrhosis *
E4
44 62 M Liver Cirrhosis * * * Cirrhosis *
E5
45 45 M Liver Cirrhosis * * * Cirrhosis *
E6
46 45 M Liver Cirrhosis * * * Cirrhosis *
E7
47 62 M Liver Cirrhosis * * * Cirrhosis *
E8
48 62 M Liver Cirrhosis * * * Cirrhosis *
E9
49 36 M Liver Cirrhosis * * * Cirrhosis *
E10
50 36 M Liver Cirrhosis * * * Cirrhosis *
F1
51 69 M Liver Cirrhosis * * * Cirrhosis *
F2
52 69 M Liver Cirrhosis * * * Cirrhosis *
F3
53 37 M Liver Cirrhosis * * * Cirrhosis *
F4
54 37 M Liver Cirrhosis * * * Cirrhosis *
F5
55 69 M Liver Cirrhosis * * * Cirrhosis *
F6
56 69 M Liver Cirrhosis * * * Cirrhosis *
F7
57 62 M Liver Cirrhosis * * * Cirrhosis *
F8
58 62 M Liver Cirrhosis * * * Cirrhosis *
F9
59 45 M Liver Cirrhosis * * * Cirrhosis *
F10
60 45 M Liver Cirrhosis * * * Cirrhosis *
G1
61 58 M Liver Adjacent normal liver tissue * * * NAT *
G2
62 58 M Liver Adjacent normal liver tissue * * * NAT *
G3
63 45 M Liver Adjacent normal liver tissue * * * NAT *
G4
64 45 M Liver Adjacent normal liver tissue * * * NAT *
G5
65 60 F Liver Adjacent normal liver tissue * * * NAT *
G6
66 60 F Liver Adjacent normal liver tissue * * * NAT *
G7
67 65 F Liver Adjacent normal liver tissue * * * NAT *
G8
68 65 F Liver Adjacent normal liver tissue * * * NAT *
G9
69 63 M Liver Adjacent normal liver tissue * * * NAT *
G10
70 63 M Liver Adjacent normal liver tissue * * * NAT *
H1
71 46 M Liver Adjacent normal liver tissue * * * NAT *
H2
72 46 M Liver Adjacent normal liver tissue * * * NAT *
H3
73 52 F Liver Adjacent normal liver tissue * * * NAT *
H4
74 52 F Liver Adjacent normal liver tissue * * * NAT *
H5
75 36 F Liver Adjacent normal liver tissue * * * NAT *
H6
76 36 F Liver Adjacent normal liver tissue * * * NAT *
H7
77 41 F Liver Adjacent normal liver tissue * * * NAT *
H8
78 41 F Liver Adjacent normal liver tissue * * * NAT *
H9
79 47 M Liver Adjacent normal liver tissue * * * NAT *
H10
80 47 M Liver Adjacent normal liver tissue * * * NAT *
_marker_
Find overlapping cases with this tissue array:
  • DLV8013a
    File Format: .xlsx
    Release Date: 2025-01-17 15:54:16
    Download
1.402858s